vs
Apellis Pharmaceuticals, Inc.（APLS）与化石集团（FOSL）财务数据对比。点击上方公司名可切换其他公司
化石集团的季度营收约是Apellis Pharmaceuticals, Inc.的1.4倍（$270.2M vs $199.9M），化石集团净利率更高（-14.8% vs -29.5%，领先14.7%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -21.1%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-22.5M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -11.4%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
化石集团是1984年成立的美国时尚设计制造企业，总部位于得克萨斯州理查森。集团旗下拥有Fossil、Relic、Michele Watch、Skagen、Zodiac Watches等多个品牌，同时也为宝马、彪马、阿玛尼、迈克高仕、DKNY等多个知名品牌代工生产授权配饰。
APLS vs FOSL — 直观对比
营收规模更大
FOSL
是对方的1.4倍
$199.9M
营收增速更快
APLS
高出15.1%
-21.1%
净利率更高
FOSL
高出14.7%
-29.5%
自由现金流更多
APLS
多$8.2M
$-22.5M
两年增速更快
APLS
近两年复合增速
-11.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $270.2M |
| 净利润 | $-59.0M | $-40.0M |
| 毛利率 | — | 49.0% |
| 营业利润率 | -25.6% | -8.0% |
| 净利率 | -29.5% | -14.8% |
| 营收同比 | -5.9% | -21.1% |
| 净利润同比 | -62.2% | -257.8% |
| 每股收益（稀释后） | $-0.40 | $-0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSFOSL
| Q4 25 | $199.9M | $270.2M | ||
| Q3 25 | $458.6M | $220.4M | ||
| Q2 25 | $178.5M | $233.3M | ||
| Q1 25 | $166.8M | — | ||
| Q4 24 | $212.5M | $342.3M | ||
| Q3 24 | $196.8M | $287.8M | ||
| Q2 24 | $199.7M | $260.0M | ||
| Q1 24 | $172.3M | $254.9M |
净利润APLSFOSL
| Q4 25 | $-59.0M | $-40.0M | ||
| Q3 25 | $215.7M | $-2.1M | ||
| Q2 25 | $-42.2M | $-17.9M | ||
| Q1 25 | $-92.2M | — | ||
| Q4 24 | $-36.4M | $-11.2M | ||
| Q3 24 | $-57.4M | $-31.9M | ||
| Q2 24 | $-37.7M | $-38.8M | ||
| Q1 24 | $-66.4M | $-24.3M |
毛利率APLSFOSL
| Q4 25 | — | 49.0% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 61.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | — | 49.4% | ||
| Q2 24 | — | 52.6% | ||
| Q1 24 | — | 52.4% |
营业利润率APLSFOSL
| Q4 25 | -25.6% | -8.0% | ||
| Q3 25 | 48.7% | 3.9% | ||
| Q2 25 | -18.6% | -2.9% | ||
| Q1 25 | -50.0% | — | ||
| Q4 24 | -12.3% | -4.8% | ||
| Q3 24 | -24.0% | -8.5% | ||
| Q2 24 | -14.7% | -13.1% | ||
| Q1 24 | -36.0% | -11.5% |
净利率APLSFOSL
| Q4 25 | -29.5% | -14.8% | ||
| Q3 25 | 47.0% | -1.0% | ||
| Q2 25 | -23.6% | -7.7% | ||
| Q1 25 | -55.3% | — | ||
| Q4 24 | -17.1% | -3.3% | ||
| Q3 24 | -29.2% | -11.1% | ||
| Q2 24 | -18.9% | -14.9% | ||
| Q1 24 | -38.5% | -9.5% |
每股收益（稀释后）APLSFOSL
| Q4 25 | $-0.40 | $-0.76 | ||
| Q3 25 | $1.67 | $-0.04 | ||
| Q2 25 | $-0.33 | $-0.33 | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | $-0.15 | ||
| Q3 24 | $-0.46 | $-0.60 | ||
| Q2 24 | $-0.30 | $-0.73 | ||
| Q1 24 | $-0.54 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $79.2M |
| 总债务越低越好 | — | $169.1M |
| 股东权益账面价值 | $370.1M | $112.6M |
| 总资产 | $1.1B | $701.0M |
| 负债/权益比越低杠杆越低 | — | 1.50× |
8季度趋势，按日历期对齐
现金及短期投资APLSFOSL
| Q4 25 | $466.2M | $79.2M | ||
| Q3 25 | $479.2M | $109.9M | ||
| Q2 25 | $370.0M | $78.3M | ||
| Q1 25 | $358.4M | — | ||
| Q4 24 | $411.3M | $123.6M | ||
| Q3 24 | $396.9M | $106.3M | ||
| Q2 24 | $360.1M | $104.9M | ||
| Q1 24 | $325.9M | $112.9M |
总债务APLSFOSL
| Q4 25 | — | $169.1M | ||
| Q3 25 | — | $165.6M | ||
| Q2 25 | — | $167.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $162.7M | ||
| Q3 24 | — | $173.4M | ||
| Q2 24 | — | $156.5M | ||
| Q1 24 | $93.1M | $202.9M |
股东权益APLSFOSL
| Q4 25 | $370.1M | $112.6M | ||
| Q3 25 | $401.2M | $150.3M | ||
| Q2 25 | $156.3M | $140.6M | ||
| Q1 25 | $164.2M | — | ||
| Q4 24 | $228.5M | $148.7M | ||
| Q3 24 | $237.1M | $164.4M | ||
| Q2 24 | $264.3M | $189.6M | ||
| Q1 24 | $266.7M | $229.1M |
总资产APLSFOSL
| Q4 25 | $1.1B | $701.0M | ||
| Q3 25 | $1.1B | $704.5M | ||
| Q2 25 | $821.4M | $686.0M | ||
| Q1 25 | $807.3M | — | ||
| Q4 24 | $885.1M | $763.6M | ||
| Q3 24 | $901.9M | $812.4M | ||
| Q2 24 | $904.5M | $785.7M | ||
| Q1 24 | $831.9M | $891.0M |
负债/权益比APLSFOSL
| Q4 25 | — | 1.50× | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 1.19× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | — | 1.06× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | 0.35× | 0.89× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-22.5M |
| 自由现金流率自由现金流/营收 | -7.1% | -8.3% |
| 资本支出强度资本支出/营收 | 0.1% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-46.0M |
8季度趋势，按日历期对齐
经营现金流APLSFOSL
| Q4 25 | $-14.2M | $-22.2M | ||
| Q3 25 | $108.5M | $9.4M | ||
| Q2 25 | $4.4M | $-60.4M | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.4M | $30.5M | ||
| Q3 24 | $34.1M | $-22.8M | ||
| Q2 24 | $-8.3M | $38.4M | ||
| Q1 24 | $-133.0M | $622.0K |
自由现金流APLSFOSL
| Q4 25 | $-14.3M | $-22.5M | ||
| Q3 25 | $108.3M | $8.6M | ||
| Q2 25 | $4.4M | $-60.6M | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | $28.5M | ||
| Q3 24 | — | $-24.1M | ||
| Q2 24 | $-8.4M | $36.6M | ||
| Q1 24 | $-133.3M | $-1.1M |
自由现金流率APLSFOSL
| Q4 25 | -7.1% | -8.3% | ||
| Q3 25 | 23.6% | 3.9% | ||
| Q2 25 | 2.5% | -26.0% | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | 8.3% | ||
| Q3 24 | — | -8.4% | ||
| Q2 24 | -4.2% | 14.1% | ||
| Q1 24 | -77.3% | -0.4% |
资本支出强度APLSFOSL
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 0.7% | ||
| Q1 24 | 0.2% | 0.7% |
现金转化率APLSFOSL
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
FOSL
| Transferred At Point In Time | $109.7M | 41% |
| Traditional Watches | $91.3M | 34% |
| Other | $50.8M | 19% |
| Leathers | $9.5M | 4% |
| Jewelry | $4.0M | 1% |
| Smartwatches | $3.3M | 1% |
| Products Other | $1.6M | 1% |
